Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - OTHER CURRENT ASSETS
Other Current Assets RARE - Ultragenyx Pharmaceutical Inc.
47.6 M
LAST VALUE
-18.53%
2 YEAR CAGR
2.13%
5 YEAR CAGR
29.12%
10 YEAR CAGR